TRUIST FINANCIAL CORP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$581,386
-26.2%
30,249
-2.4%
0.00%0.0%
Q2 2023$787,512
-32.6%
30,980
-4.1%
0.00%
-50.0%
Q1 2023$1,168,296
-8.1%
32,318
+0.7%
0.00%0.0%
Q4 2022$1,271,160
+18.0%
32,100
+38.9%
0.00%0.0%
Q3 2022$1,077,000
-23.2%
23,106
-27.7%
0.00%
-33.3%
Q2 2022$1,402,000
-15.5%
31,979
+39.4%
0.00%0.0%
Q1 2022$1,660,000
-27.7%
22,947
-19.0%
0.00%0.0%
Q4 2021$2,296,000
-45.7%
28,315
-22.1%
0.00%
-57.1%
Q3 2021$4,229,000
-31.3%
36,342
-2.2%
0.01%
-30.0%
Q2 2021$6,160,000
+37.7%
37,155
+15.9%
0.01%
+25.0%
Q1 2021$4,472,000
+8.0%
32,056
+34.1%
0.01%0.0%
Q4 2020$4,139,000
+50.2%
23,908
+20.9%
0.01%
+33.3%
Q3 2020$2,756,000
+42.2%
19,781
+22.0%
0.01%
+50.0%
Q2 2020$1,938,000
+41.2%
16,219
+18.1%
0.00%0.0%
Q1 2020$1,373,000
-19.9%
13,734
-5.8%
0.00%
+33.3%
Q4 2019$1,714,00014,5780.00%
Other shareholders
NEVRO CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders